These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9734972)

  • 1. Losartan and renal transplantation.
    Aurup P; Smith RD
    Lancet; 1998 Mar; 351(9107):990. PubMed ID: 9734972
    [No Abstract]   [Full Text] [Related]  

  • 2. Losartan and renal transplantation.
    Horn S; Holzer H; Horina J
    Lancet; 1998 Jan; 351(9096):111. PubMed ID: 9439500
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of losartan in renal transplant recipients.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1999 Dec; 31(8):3300-1. PubMed ID: 10616484
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
    Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is losartan as effective as enalapril on posttransplant persistent proteinuria?
    Altiparmak MR; Trablus S; Apaydin S; Başar O; Sariyar M; Serdengeçti K; Erek E
    Transplant Proc; 2001; 33(7-8):3368-9. PubMed ID: 11750440
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
    Tsang WK; Tong KL; Chan HW
    Transplant Proc; 1998 Nov; 30(7):3072-3. PubMed ID: 9838354
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
    Shand BI; Lynn KL
    Clin Nephrol; 2000 Nov; 54(5):427-8. PubMed ID: 11105808
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of severe proteinuria with losartan after renal transplantation.
    Navarro JF; Macía ML; García J
    Am J Nephrol; 1998; 18(3):261-2. PubMed ID: 9627049
    [No Abstract]   [Full Text] [Related]  

  • 9. [A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis].
    Khazine F; Simons O
    Nephrologie; 2001; 22(2):73. PubMed ID: 11385903
    [No Abstract]   [Full Text] [Related]  

  • 10. Losartan and hypertensive children. Another option for a small number of children.
    Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20939445
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction.
    Lee S
    Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875
    [No Abstract]   [Full Text] [Related]  

  • 12. [AT1 receptor antagonist lorsartan and organ protection. Managing hypertension a different way].
    MMW Fortschr Med; 2006 Mar; 148(13):48-9. PubMed ID: 16642707
    [No Abstract]   [Full Text] [Related]  

  • 13. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
    Hortal L; Fernández A; Vega N; Rodríguez JC; Losada A; Lorenzo M; Plaza C; Palop L
    Transplant Proc; 1998 Aug; 30(5):2127-8. PubMed ID: 9723415
    [No Abstract]   [Full Text] [Related]  

  • 14. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
    MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan use in mild to moderate hypertension--adverse effects in moderate to severe renal failure.
    Gupta S; Dash SC; Bhowmik D; Mohanty NK; Agarwal SK; Tiwari SC
    J Assoc Physicians India; 2001 May; 49():591. PubMed ID: 11361289
    [No Abstract]   [Full Text] [Related]  

  • 18. [New antihypertensive drugs: reasons for hope].
    Unger T
    Fortschr Med; 1997 Sep; 115(26):58-9. PubMed ID: 9417415
    [No Abstract]   [Full Text] [Related]  

  • 19. [Israeli experiences of treatment of hypertension with losartan (Ocsaar)--summary of the treatment of 421 patients in community health centers].
    Zimlichman R
    Harefuah; 1999 Dec; 137(12):597-603, 680. PubMed ID: 10959382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan in the treatment of hypertension: mechanism, efficacy and safety. Proceedings of a meeting. November 19-20, 1993. Lisbon, Portugal.
    J Hypertens Suppl; 1995 Jul; 13(1):S1-80. PubMed ID: 18846644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.